IRIDEX CORP (IRIX) Form 8-K — Nov 17, 2026
Iridex reported Q3 2026 revenue of $10.2 million, down 19% from $12.5 million a year ago, as weak demand in Europe and Asia, distributor inventory destocking, and regulatory challenges hurt international sales. Gross margin improved to 42.4% from 32.1%, and net loss narrowed slightly to $1.4 million ($0.08 per share). The company cut its full-year 2026 revenue guidance to $46-48 million from $51-53 million, citing Q3 trends expected to persist into Q4. Adjusted EBITDA loss widened to $0.6 million from $0.1 million.
Key figures
- Revenue
- 10156000
- Guidance
- FY2026 revenue reduced to $46-48 million from $51-53 million; adjusted operating expenses of $19-19.5 million
- Total Debt
- 3825000
- Revenue Yoy
- -19%
- Total Assets
- 29272000
- Cash Position
- 3673000
- Shares Outstanding
- 17593000
- Gross margin
- 42.4% (vs 32.1% prior year; 38.7% pro forma)
- Retina revenue
- $5.1 million vs $6.7 million prior year
- Cyclo g6 revenue
- $3.2 million vs $3.5 million prior year
- Operating expenses
- $5.5 million (vs $5.4 million prior year)
- Q cash utilization
- $1.0 million
- Adjusted ebitda loss
- $0.6 million vs $0.1 million loss prior year
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.